Remdesivir may offer kidney, CV benefits for transplant recipients with acute COVID-19

Kidney transplant recipients with acute COVID-19 had reduced risks for graft loss and CV events when they receive early remdesivir, according to study data published in JAMA Network Open. Kidney transplant recipients particularly face risks for severe COVID-19 due to comorbidities, receipt of immunosuppressive medications and other factors, according to Nitipong (Nate) Permpalung, MD, MPH,